Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up

Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up

BD-related costs remained stable over two years. However, the proportion of anti-TNF-related healthcare costs increased, while hospitalization costs decreased. Factors associated with increased costs were penetrating disease course in CD and age

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PLoS ONE 2016-04, Vol.11 (4)
Hauptverfasser: Valk, M.E. van der, Mangen, M.J.J., Severs, M., Have, M. van der, Dijkstra, G., Bodegraven, A.A. van, Fidder, H.H., Jong, D.J. de, Woude, C.J. van der, Romberg-Camps, M.J.L., Clemens, C.H.M., Jansen, J.M., Meeberg, P.C.V. de, Mahmmod, N., Meulen-de Jong, A.E. van der, Ponsioen, C.Y., Bolwerk, C., Vermeijden, J.R., Siersema, P.D., Leenders, M., Oldenburg, B.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BD-related costs remained stable over two years. However, the proportion of anti-TNF-related healthcare costs increased, while hospitalization costs decreased. Factors associated with increased costs were penetrating disease course in CD and age
DOI:10.1371/journal.pone.0142481